Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study end
Awards & highlights
Study Summary
The main purpose of this research study is to evaluate the safety and dosing of CG0070.
Eligible Conditions
- Bladder Cancer
- Transitional Cell Carcinoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study end
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study end
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Maximum-tolerated or maximum feasible dose in single and multidose regimens of CG0070 by intravesical administration
Secondary outcome measures
Assessment of the amount of CG0070 in the urine and blood over time by PCR
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Cell GenesysLead Sponsor
15 Previous Clinical Trials
1,568 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger